BioMed Innovations

At BioMed Innovations, we’re revolutionizing the way new drugs are discovered by utilizing our proprietary technology that accelerates preclinical testing. Our platform enables pharmaceutical companies to streamline their processes, cutting down the average drug development timeline by up to 50%. We have already secured initial partnerships with two major biotech firms, resulting in $500,000 in revenue over the past year. Our team has a combined 25 years of experience in pharmaceuticals and biotechnology, ensuring we have the expertise to bring our innovations to market effectively. With the biotech sector projected to grow at a CAGR of 7% through 2030, the potential for our technology is immense. However, to capitalize on this opportunity, we need to raise $900,000 to expand our lab facilities and enhance our marketing efforts. This is a founder-led project looking for investment, operating support and long-term business discipline. The requested funding will help us scale operations and enhance our R&D capabilities. A biotechnology company focused on accelerating drug development processes through innovative preclinical testing technology.

The $900,000 investment will be allocated as follows:

• $400,000 for upgrading laboratory equipment and facilities.
• $300,000 for hiring additional R&D personnel and specialists.
• $100,000 for marketing and partnership development.
• $100,000 for operational expenses in the first year as we scale up.